Gilead Sciences Inc articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/09/16 02:32
2014/09/16 02:32
14h
Gilead Sciences has reached a deal with several generic drugmakers to produce a cheaper version of its popular, $1,000-per-pill hepatitis C drug Sovaldi for use in developing countries. Gilead said...
2014/09/16 02:32
2014/09/16 02:32
Latest videos
2014/09/15 21:12
2014/09/15 21:12
20h
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market: Alere Inc., up $4.53 to $41.14 The health services company's...
2014/09/15 17:52
2014/09/15 17:52
23h
Gilead Sciences Inc. may have scored some points on the public relations front, but it didn’t get any sympathy from investors Monday as it announced a plan to offer deep discounts for its...
2014/09/15 12:19
2014/09/15 12:19
1d
Gilead licenses hepatitis C drug to Cipla, Ranbaxy, 5 others | GlobalPost Please support our site by enabling javascript to view info. Please support our site by enabling javascript to view...
2014/09/12 17:16
2014/09/12 17:16
4d
The phones rang a lot more than usual this summer at Biondo Group LLC, the small Pennsylvania investment firm tucked away near the Delaware Water Gap and the foothills of the Pocono Mountains. Rather...
Read more at BusinessWeek, Bloomberg
2014/09/11 22:09
2014/09/11 22:09
4d
The Standard & Poor's 500 Index erased losses Thursday, sending the gauge higher for a second day, as a rebound in oil offset concerns over escalating geopolitical tension and the timing of possible...
2014/09/10 19:49
2014/09/10 19:49
5d
An analyst’s note gushing over the prospects of a line of new lymphoma and leukemia drugs helped keep shares of a contingent of drug makers out of the red Wednesday and sent a few to significantly...
2014/09/06 06:21
2014/09/06 06:21
10d
U.S. stocks rose, with the Standard & Poor's 500 index erasing a weekly loss, as geopolitical tensions eased and lower-than-estimated jobs data fueled bets that the Federal Reserve won't rush to raise...
2014/09/05 16:16
2014/09/05 16:16
11d
Estimates of U.S. health-care spending for the next five years have been lowered by two federal agencies, and the Patient Protection and Affordable Care Act is getting much of the credit. U.S. health...
2014/09/05 15:22
2014/09/05 15:22
11d
NEW YORK (TheStreet) -- Shares of Gilead Sciences (GILD) fell -4.79% to $101.74 in morning trading Friday after Bloomberg reported the company is close to a deal with generic drugmakers to bring...
2014/09/03 03:21
2014/09/03 03:21
13d
After 11 years with InterMune, Chairman, President and CEO Daniel Welch could walk away with a severance package of more than $36 million. InterMune Inc.’s pending $8.3 billion takeover by Roche will...
2014/09/01 03:06
2014/09/01 03:06
15d
Cipla Ltd. (CIPLA) shot to prominence a decade ago by selling AIDS drugs for $1 a day in Africa. Now the Indian generics maker is seeking a bigger slice of the U.S. market with cheaper medicines for...
2014/08/31 02:42
2014/08/31 02:42
16d
Le Bonheur Children's Hospital and the University of Tennessee Health Science Center researcher Infectious Disease Specialist John DeVincenzo, MD, is lead author of this study. RSV is the most common...
2014/08/26 12:34
2014/08/26 12:34
21d
A Wall Street sign is pictured outside the New York Stock Exchange in New York. New York - US stock index futures were little changed on Tuesday, with investors finding few reasons to buy after a...
2014/08/26 11:50
2014/08/26 11:50
21d
Futures flat, few incentives to buy; S&P 500 off record NEW YORK (Reuters) - U.S. stock index futures were little changed on Tuesday, with investors finding few reasons to buy after a rally in the...
2014/08/25 14:28
2014/08/25 14:28
22d
Bloomberg News Roche Holding AG, the world's largest maker of cancer drugs, is strengthening its portfolio of medicines for respiratory ailments with an agreement to buy InterMune Inc. for $8.3...
2014/08/20 13:39
2014/08/20 13:39
27d
Operating profit margin (OPM) indicates how much profit a company makes after paying for the costs of production, and is indicated as a percentage of sales. To be included, companies had to increase...
2014/08/19 12:49
2014/08/19 12:49
28d
Now that second-quarter earnings season is nearly over, it’s time to find out which companies moved up the ranks in their industry. But how do we find out? Earnings results are so often affected by...
2014/08/18 15:31
2014/08/18 15:31
29d
LOS ANGELES (Reuters) - Biotech drug production techniques based on plants, which may prove to be faster, higher yielding and cheaper than current methods using mammalian cells, haven't caught on with...
2014/08/16 07:34
2014/08/16 07:34
1m
The tech-heavy Nasdaq was lifted by gains in stocks like Gilead and Microsoft. New York - US stocks ended mixed on Friday, paring an earlier selloff sparked by reports of Ukraine shelling a Russian...
Read more at iol.co.za, The Star
2014/09/16 02:32
2014/09/16 02:32
Latest from Twitter